This could be crucial for neuroblastoma, as the combination of cancer therapeutics and IGF axis inhibitors has been proven to be beneficial in diverse preclinical models.[43] Importantly, observed effects were MYCN independent since this oncogene did not change in our inducible‐LIN28B cellular model.[44, 45]. Here, MYCN is linked to neuroblastoma.